Sheila M. Grant
Chief Tech/Sci/R&D Officer bei XENON PHARMACEUTICALS INC.
Profil
Sheila M.
Grant is currently the Executive VP-Research & Development Operations at Xenon Pharmaceuticals, Inc. Prior to her current position, she served as the Chief Operating Officer at Correvio Pharma Corp.
from 2013 to 2020.
Additionally, she worked as a Consultant at Twinstrand Therapeutics, Inc. Ms. Grant holds an MBA from Simon Fraser University, a graduate degree from the London School of Hygiene & Tropical Medicine, and an undergraduate degree from the University of Essex.
Aktive Positionen von Sheila M. Grant
| Unternehmen | Position | Beginn |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 01.08.2020 |
Ehemalige bekannte Positionen von Sheila M. Grant
| Unternehmen | Position | Ende |
|---|---|---|
| CORREVIO PHARMA CORP. | Chief Operating Officer | 27.05.2020 |
Twinstrand Therapeutics, Inc.
 Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Corporate Officer/Principal | - |
Ausbildung von Sheila M. Grant
| Simon Fraser University | Masters Business Admin |
| London School of Hygiene & Tropical Medicine | Graduate Degree |
| University of Essex | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| XENON PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
Twinstrand Therapeutics, Inc.
Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Health Technology |
